Monday, April 22, 2024 | Baltimore, MD

Gaithersburg’s Novavax slashing workforce, chopping expenses ahead of fall Covid-19 vaccine launch

May 10, 2023

Gaithersburg’s Novavax Inc. (NASDAQ: NVAX) is taking more aggressive steps to preserve its cash and ensure it can stay in business — slashing a quarter of its workforce, consolidating its real estate and paying down liabilities — before its planned fall launch of a new Covid-19 vaccine. The local biotech said Tuesday the restructuring should help reduce its 2023 research and development spending and sales, general and administrative expenses by 20% to 25% compared to last year.

Article Source: Baltimore Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.